Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack Ketamine and Esketamine in Psychiatric Practice: What PMHNPs Need to Know in 2026.

Ketamine and esketamine are reshaping treatment-resistant depression care, with expanded indications and new delivery models emerging in 2026. PMHNPs must understand the differences between IV ketamine, intranasal esketamine (Spravato), and oral ketamine, including REMS requirements, monitoring protocols, and scope of practice considerations.

Read the full post: https://psychnpfellowship.com/ketamine-esketamine-psychiatric-practice-pmhnp-2026/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack How to Find a PMHNP Mentor — A Practical Guide.

Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. If you’ve typed “how to find a PMHNP mentor” into a search bar, you already know the answer isn’t simple. Unlike medical residencies where mentorship is built into the structure, psychiatric nurse practitioners are largely expected to transition to independent practice with minimal support. This guide breaks down the realistic options available to you, what to look for in a mentor, and why many PMHNPs are turning to structured mentorship programs instead of trying to find individual mentors on their own. Why Finding a Mentor Is So Hard The PMHNP workforce is growing rapidly — the Bureau of Labor Statistics projects 40%+ growth

Read the full post: https://psychnpfellowship.com/how-to-find-a-pmhnp-mentor/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack Buprenorphine Prescribing for PMHNPs: What Changed After the X-Waiver Elimination.

With the X-waiver eliminated, all DEA-licensed PMHNPs can now prescribe buprenorphine for opioid use disorder without special certification. This guide covers the practical clinical workflow including induction protocols, dosing strategies, urine drug screening, and documentation requirements.

Read the full post: https://psychnpfellowship.com/buprenorphine-prescribing-pmhnp-x-waiver-elimination-guide/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack PMHNP Imposter Syndrome — Why You Feel Like a Fraud (And What to Do About It).

Imposter syndrome affects up to 70% of new PMHNPs, creating self-doubt that can stall clinical growth and lead to burnout. Understanding that this is a normal developmental stage, not a character flaw, is the first step. Evidence-based strategies like structured mentorship, competency tracking, and cognitive reframing can help you move from paralysis to confident practice.

Read the full post: https://psychnpfellowship.com/pmhnp-imposter-syndrome/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack Starting a Psychiatric Private Practice in 2026: The Complete PMHNP Roadmap.

Launching a psychiatric private practice as a PMHNP in 2026 requires navigating credentialing, insurance paneling, EHR selection, and business formation. This step-by-step roadmap covers everything from LLC formation to getting your first patients, with timelines and cost estimates for each phase.

Read the full post: https://psychnpfellowship.com/starting-psychiatric-private-practice-2026-pmhnp-guide/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack Lithium Prescribing in 2026: Updated Renal Safety Guidelines for PMHNPs.

New 2026 consensus guidelines revise lithium renal monitoring protocols, recommending eGFR checks every 3 months for the first year and introducing risk-stratified monitoring thereafter. PMHNPs prescribing lithium should update their lab schedules and understand the new evidence on long-term renal outcomes.

Read the full post: https://psychnpfellowship.com/lithium-prescribing-renal-safety-guidelines-2026-pmhnp/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack Clozapine Monitoring Updates 2026: REMS Changes Every PMHNP Must Know.

The FDA has streamlined clozapine REMS requirements for 2026, reducing ANC monitoring frequency for established patients while maintaining safety guardrails. PMHNPs prescribing clozapine need to understand the new tiered monitoring schedule, updated dispensing rules, and documentation changes that take effect this year.

Read the full post: https://psychnpfellowship.com/clozapine-monitoring-rems-changes-2026-pmhnp/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack PMHNP Mentorship That Makes a Difference.

Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. You earned your degree. You passed your boards. And then you sat down across from your first real patient — the one whose chart didn’t match any textbook case study you’d ever seen — and thought: What do I actually do now? If that sounds familiar, you’re not alone. Studies consistently show that new-graduate nurse practitioners report feeling underprepared for independent clinical practice, even from excellent programs. The gap between academic training and confident real-world practice is well-documented — and it’s not because the education was bad. It’s because clinical confidence is built through experience, mentorship, and

Read the full post: https://psychnpfellowship.com/pmhnp-mentorship-that-makes-a-difference/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack DEA Telehealth Prescribing Rules for 2026: What PMHNPs Running a Practice Need to Know.

The DEA extended telehealth prescribing flexibilities for controlled substances through December 31, 2026 . PMHNPs can continue prescribing Schedule II-V meds via video without a prior in-person visit — but permanent rules are coming, and they’ll likely tighten requirements. If you’re building or running a telehealth practice, now is the time to audit your documentation, build hybrid workflows, and prepare for a Special Registration for Telemedicine that may become mandatory. The window to build your practice on the current rules is closing.

Read the full post: https://psychnpfellowship.com/dea-telehealth-prescribing-rules-2026-pmhnp/

Hey! I'd love to hear your thoughts, send me a voice note.

In this deep-dive episode, we unpack FDA ADHD Stimulant Label Change: Weight Loss Risk PMHNPs Must Know.

The FDA now requires all extended-release ADHD stimulants to carry a Limitation of Use warning about weight loss risk in children under 6. Younger kids get higher plasma exposures from ER formulations, leading to clinically significant weight loss (10%+ drop in CDC weight percentile). PMHNPs need a structured monitoring protocol: baseline weight, monthly checks for 3 months, quarterly thereafter, and a 10% percentile drop as the intervention threshold. Immediate-release formulations are not included in this label change and may be preferable for very young patients.

Read the full post: https://psychnpfellowship.com/fda-adhd-stimulant-label-change-weight-loss-pmhnp/